Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccine
The clinical trials from which data were extracted are registered at www.clinicaltrials.gov (identifiers are NCT02193087, NCT01511250, NCT02302066, NCT02425098, NCT03746015, NCT02747927, NCT03999996, NCT03423173, NCT03342898, NCT03771963, NCT04313244, NCT02948829, NCT035252119, NCT03341637).
Authors
- Sanjay S. Patel (ORCID: https://orcid.org/0000-0001-7621-453X)
- Hang Pang
- Olaf Zent
- Martina Rauscher (ORCID: https://orcid.org/0000-0002-9908-8852)
- Alice Faccin
- Zeb Youard
Institutions
- Takeda (United States) (US)
- Takeda (France) (FR)
- Takeda (Japan) (JP)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1080/14760584.2025.2480297
- Citations
- 4
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 7.51
Funders
- Takeda Pharmaceuticals International